Biologics in rotator cuff repair.

Bone Joint J · Sep 01 2024 · Review

Savoie Iii FH, Delvadia BP, Tate JP, Winter JE, Williams GH, Sherman WF, et al.

Department of Orthopaedic Surgery, Tulane University School of Medicine, New Orleans

Shoulder & Elbow Sports Medicine

SUMMARY — THE REDUCTIONThis review summarizes current evidence on biologic augmentation strategies aimed at improving rotator cuff healing and reducing retear rates after repair.
Abstract, as published

Rotator cuff tears are common in middle-aged and elderly patients. Despite advances in the surgical repair of rotator cuff tears, the rates of recurrent tear remain high. This may be due to the complexity of the tendons of the rotator cuff, which contributes to an inherently hostile healing environment. During the past 20 years, there has been an increased interest in the use of biologics to complement the healing environment in the shoulder, in order to improve rotator cuff healing and reduce the rate of recurrent tears. The aim of this review is to provide a summary of the current evidence for the use of forms of biological augmentation when repairing rotator cuff tears.

Featured in the 2026-07-28 issue.

← Batter's Shoulder: Diagnosis, Management, and Outcomes.Tendon transfers for the management of irreparable subscapula… →

The Reduction is a free email digest of newly published orthopaedic literature — a handful of new papers in the subspecialties you choose, each summarized like this one. Subscribe free or browse the archive.